10Blade, -Well, you right , in phase 2 it is really not that important how you call those endpoints .. this is a pick from the sponsor ( company ) in what symptoms their drug will make a difference..

At the end they putting together the biggest improvement they see , and this becoming primary endpoint for phase 3 ..

It is very important to meet primary endpoint in phase 3...

Here in our phase 2 Dr Lalezari designed primary endpoints , as he said , mostly what other people do..

I actually was surprised with his choice , those were not really objective endpoints...

But we lucky , the most important parameters to evaluate progress of our patients are in our NEWS2 , and we did very well...

I guess it is good that Royal College of Physicians in England , designed such an important endpoints for us ..

Great..

And all imo..